PubMed HealthSearch

PubMed · 8671110

Doing randomized controlled trials in a developing country: some practical realities.

Abstract

BACKGROUND: Formal randomized controlled trial results are often reported. The difficulties of doing such trial are not. Developing countries represent a new field in which trials can be undertaken. In this context even less is known about the practicalities involved. METHOD AND RESULTS: A randomized, double-blind, parallel study took significantly longer than expected to complete and subject recruitment and participation fell short of expectations. Different recruitment strategies were used and these performed differently in terms of enrolling trialists. Subjects most frequently left the trial in its early stages. CONCLUSIONS: Possible explanations for these findings include the demography of the country, cultural factors, and the existence of an established doctor-patient relationship.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N J Glasgow, J C Murdoch, L Baynouna, M M al Sabosy, O N al Jabiri, D W Harron. 1996. Doing randomized controlled trials in a developing country: some practical realities.. https://doi.org/10.1093/fampra%2F13.1.98

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Treatment of arterial hypertension with renal involvement].

TREATMENT GUIDELINES: To prevent the development of hypertensive renal disease of progression of underlying renal disease, the blood pressure goal should be 130/85 mmHg or less if possible when proteinuria exceeds 1 g/24 h. ANTIHYPERTENSIVE DRUGS: Converting enzyme inhibitors are recommended in patients with non-diabetic renal disease and, as first-line therapy, in diabetics with microalbuminurea or patent diabetic nephropathy with or without hypertension. TREATMENT ONSET: Converting enzyme inhibitors should be started progressively with a lower final dosage in case of renal failure. Creatinemia and kaliemia must be monitored. Combination therapy with diuretics is generally used, but potassium-sparing diuretics are contraindicated due to the risk of hyperkaliemia. Reduced sodium intake is essential to obtain maximum effect.

Antihypertensive Agents